GSK plc
GSK
$37.56
$0.411.10%
NYSE
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -5.76% | 285.78% | 802.46% | -105.10% | 11.56% |
| Total Depreciation and Amortization | 49.36% | 302.68% | -79.20% | 53.52% | 15.79% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -194.16% | -95.14% | 584.01% | -10.27% | -1,150.18% |
| Change in Net Operating Assets | 68.26% | -187.44% | -128.33% | 633.08% | 47.23% |
| Cash from Operations | 94.15% | -51.65% | 6.41% | 99.64% | 15.58% |
| Capital Expenditure | -30.54% | 62.40% | -75.53% | -4.18% | -21.15% |
| Sale of Property, Plant, and Equipment | 430.31% | -98.39% | 5,903.24% | -48.42% | 98.97% |
| Cash Acquisitions | 99.60% | -1,114.95% | -1,499.22% | 87.50% | 95.45% |
| Divestitures | -2,869.69% | 80.33% | -64.02% | 55.79% | -132.13% |
| Other Investing Activities | -173.53% | 76.89% | -32.62% | -139.03% | 34.18% |
| Cash from Investing | 42.05% | -0.54% | -50.65% | -197.93% | 614.11% |
| Total Debt Issued | -68.95% | 54.88% | -- | -- | -- |
| Total Debt Repaid | -627.78% | 81.27% | -90.89% | -1.34% | -56.84% |
| Issuance of Common Stock | -83.33% | -- | -100.00% | 0.00% | -94.44% |
| Repurchase of Common Stock | -127.13% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.69% | 1.65% | 1.59% | 3.17% | -14.20% |
| Other Financing Activities | -47.44% | 62.68% | -1,572.00% | 92.58% | -159.23% |
| Cash from Financing | -393.22% | 200.21% | 33.17% | 19.25% | -48.66% |
| Foreign Exchange rate Adjustments | -150.69% | -254.54% | 120.26% | -338.41% | 58.11% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -215.94% | 122.39% | 147.68% | -47.18% | 207.22% |